782
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Triterpenes and phenolic compounds isolated from the aerial parts of Herissantia tiubae and evaluation of 5,4′,-dihydroxy-3,6,7,8,3′-pentamethoxyflavone as a modulator of bacterial drug resistance

, , , , , , , & show all
Pages 279-284 | Accepted 02 Jul 2008, Published online: 01 Apr 2009
 

Abstract

In our continuous study of the Malvaceae family, we describe here the isolation of four triterpenes (frideline, lupeol, cycloartenol, and cycloeucalenol), a steroid (β-sitosterol), and four phenolic compounds from the aerial parts of Herissantia tiubae (K. Schum.) Brizicky (i.e., a benzoic acid derivative, a coumarin and two flavonoids, kaempferol 7-O-α-l-rhamnopyranoside and 4′,5-dihydroxy-3,6,7,8,3′-pentamethoxyflavone). The structural identification of the compounds was made by comparison with literature data and spectral analysis, including two-dimensional NMR techniques. These compounds are reported here for the first time in genus Herissantia. The pentamethoxyflavone was assayed against strains of Staphylococcus aureus possessing efflux mechanisms of resistance to norfloxacin, tetracycline, and erythromycin. Although the compound did not display relevant antibacterial activity (MIC ≥ 512 μg/mL), it modulated the activity of antibiotics, i.e., in combination with antibiotics (at 128 μg/mL), a two-fold reduction in the MIC values for tetracycline and erythromycin, a 32-fold reduction in the MIC for norfloxacin were observed.

View correction statement:
Corrigendum

Acknowledgements

J.P.S-J. and V.S.F-S. are very grateful to Dr. Simon Gibbons (University of London) for his valuable and kind cooperation. CNPq (PIBIC/UFPb) is thanked for the award of an undergraduate studentship. This work was supported by the following Brazilian agencies: CNPq and CAPES.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.